Pressure BioSciences, Inc. (OTCMKTS:PBIO – Get Free Report) crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.01 and traded as low as $0.00. Pressure BioSciences shares last traded at $0.00, with a volume of 223 shares traded.
Pressure BioSciences Stock Performance
The stock has a market capitalization of $193,351.50, a PE ratio of 0.00 and a beta of -0.41. The business’s 50 day moving average is $0.01 and its 200 day moving average is $0.01.
Pressure BioSciences (OTCMKTS:PBIO – Get Free Report) last released its earnings results on Friday, February 7th. The company reported ($0.15) earnings per share for the quarter.
Pressure BioSciences Company Profile
Pressure BioSciences, Inc develops and sells pressure-based platform solutions in the North America, Europe, and Asia. The company's pressure cycling technology (PCT) technology uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to control the actions of molecules in biological samples, including cells and tissues from human, animal, plant, and microbial sources.
Further Reading
- Five stocks we like better than Pressure BioSciences
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- What is the Nasdaq? Complete Overview with History
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Pressure BioSciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pressure BioSciences and related companies with MarketBeat.com's FREE daily email newsletter.
